Barry Hock

6PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Humoural immunology and immunochemistryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomedicineAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 03, 2026
Parallel processing of T cells and natural killer cells to enhance in vivoCAR T cell activity against blood and solid cancers.

|Nov 24, 2023
Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing.

Paula E Keating, Barry D Hock, Stewart M Smith

|Sep 15, 2023
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab.

Barry D Hock, Liping Goddard, Sean A MacPherson

|Jun 20, 2020
Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies.

Barry D Hock, Judith L McKenzie, Matthew Strother

|Nov 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre.

Barry D Hock, Katie S Mulholland, Peter Ganly

|Aug 10, 2018
Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.

Murray L Barclay, Shwan Karim, Esther T Johanna Helms

Pageof 1

Frequent Collaborators

2 joint publications

Murray L Barclay

1 joint publications

Paula E Keating

1 joint publications

Paul K L Chin

1 joint publications

John L O'Donnell